2.1. Participants
painful symptoms, chronic musculoskeletal pain, musculoskeletal pain
MAY, SYNDROME, BLIND
From a population of 95 patients, 32 subjects (17 men and 15 women) with painful symptoms in the musculoskeletal system, aged between 28 and 68 years old (50.06 ± 10.85), were enrolled in the study. Patients were recruited from April to May 2022 from the physiotherapy center “Centro FisioterapicoApuano” in Lucca (Italy) where the study was also conducted.All patients who were considered eligible for the study had chronic musculoskeletal pain (of more than 3 months’ duration) [Participants were recruited after being evaluated by a physiotherapist from the center, who confirmed a diagnosis of musculoskeletal pain syndrome and collected participants’ pharmacological information through an in-person interview. Prior to the start of the study, informed consent was read and signed by each patient. The study was approved by the local institutional review committee (Prot. N. 12774E_spe). Each subject was blind to study design, outcome, and group allocation.